Position in NVO
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$378,006
+$378,006 QoQ
Shares Held
7,885
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#809
of 1,348 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Derivatives in NVO
reported options exposure · as of Dec 31, 2025CallValue
$610,560
CallShares
12,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026United Advisor Group, LLC holds $12,073,291 across 8 Drug Manufacturers - General names. NVO ranks #8 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
9,007 | $2,287,507 | |
| 2 | PFE |
Pfizer Inc
|
89,061 | $2,144,588 | |
| 3 | LLY |
ELI LILLY & Co
|
1,561 | $1,872,310 | |
| 4 | MRK |
Merck & Co., Inc.
|
14,125 | $1,815,062 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
28,224 | $1,626,266 | |
| 6 | ABBV |
AbbVie Inc.
|
5,691 | $1,432,083 | |
| 7 | AMGN |
Amgen Inc
|
1,429 | $517,469 | |
| 8 | NVO |
Novo Nordisk A S
This page
|
7,885 | $378,006 |
All Filings in NVO
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $378,006 | 7,885 | Shares | Sole | 2026-07-29 | |
| 2025-12-31 | $610,560 | 12,000 | Call | Sole | 2026-01-26 | |
| No filing history on record for this holder in this stock. | ||||||